• Actin–Myosin II Network Controls DEV Proliferation via VP26

  2026-07-15

  This study identifies host cytoskeletal proteins—especially actin and myosin II—as critical partners of the duck enteritis virus (DEV) VP26 protein using a proteomic approach. Functional assays with actin polymerization inhibitors, including Latrunculin A, demonstrate that disrupting the cytoskeleton significantly reduces viral proliferation, highlighting new targets for antiviral research.

• Aconitase Activity Colorimetric Assay Kit: Precision in TCA

  2026-07-14

  Leverage the Aconitase Activity Colorimetric Assay Kit for rapid, quantitative insights into mitochondrial aconitase function and oxidative stress dynamics. Its high-throughput, colorimetric workflow streamlines metabolic research, empowering studies from immunometabolism to translational biomarker discovery.

• Valemetostat: Dual EZH1/2 Inhibition for ATL—Mechanistic Ins

  2026-07-14

  The reference study details the first clinical approval of valemetostat, a dual EZH1/2 inhibitor, for relapsed or refractory adult T-cell leukemia/lymphoma (ATL). By targeting complementary epigenetic regulators, valemetostat addresses resistance mechanisms seen with single-agent EZH2 inhibition and opens new avenues for treating refractory hematological malignancies.

• Electrospun Silk Fibroin-CNT Fibers for Fibroblast Activatio

  2026-07-13

  This study introduces electrospun silk fibroin-carbon nanotube (SF-CNT) composite fibers that mimic native extracellular matrix alignment, enabling electrical stimulation and activation of patient-derived fibroblasts. The work demonstrates significant improvements in mechanical and electrical properties of the biocomposite, and highlights its potential for targeted tissue repair applications.

• Phosbind Acrylamide: Elevating Phosphorylation Analysis in S

  2026-07-13

  Phos binding reagent (Phosbind) acrylamide enables precise, antibody-free detection of protein phosphorylation, streamlining SDS-PAGE workflows for signaling research. Its unique phosphate-binding mechanism advances kinase studies and secondary metabolism research, especially in plant systems.

• Clasto-Lactacystin β-lactone: Precision Proteasome Inhibitio

  2026-07-12

  Explore how Clasto-Lactacystin β-lactone empowers translational researchers to dissect the ubiquitin-proteasome pathway across cancer, neurodegeneration, and viral immunity. This thought-leadership article blends mechanistic insight, strategic protocol guidance, and a forward-looking perspective rooted in current evidence—highlighting the unique value of APExBIO's potent, irreversible proteasome inhibitor.

• RAS/PI3K Mutations Sensitize Ovarian Cancer to PARP/NAMPT In

  2026-07-10

  This study identifies RAS/PI3K pathway mutations as predictive biomarkers for enhanced response to combined PARP and NAMPT inhibition in epithelial ovarian cancer. The findings offer a mechanistic rationale for targeting NAD+ metabolism alongside DNA repair pathways to overcome resistance in high-grade serous carcinoma.

• Oxaliplatin (SKU A8648): Reliable Solutions for Lab Assays

  2026-07-09

  This article delivers scenario-driven guidance for laboratory scientists utilizing Oxaliplatin (SKU A8648) in viability, proliferation, and cytotoxicity assays. It addresses common workflow challenges and provides evidence-based recommendations, positioning Oxaliplatin as a reproducible, data-backed solution for cancer research and DNA damage studies.

• Clasto-Lactacystin β-lactone: Precision Proteasome Inhibitio

  2026-07-09

  Clasto-Lactacystin β-lactone delivers unparalleled specificity and potency for studying protein degradation and cell death pathways, outperforming traditional proteasome inhibitors in both sensitivity and irreversibility. Its role in dissecting viral immune evasion and disease models makes it the tool of choice for advanced ubiquitin-proteasome pathway research.

• Gramine’s Mechanistic Utility in Ferroptosis Pathway Researc

  2026-07-08

  Explore how Gramine, a powerful ferroptosis inducer, enables high-resolution interrogation of the CUL3–MTDH axis in cancer biology research. This article provides advanced mechanistic insights and practical protocol guidance distinct from prior reviews.

• Lactobacillus gasseri ATCC33323 Modulates Colitis via NR1I3–

  2026-07-08

  Qian et al. (2024) reveal that Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by enhancing intestinal barrier integrity through NR1I3-mediated regulation of E-cadherin. Their mechanistic and genetic insights highlight new probiotic therapeutic avenues for IBD and offer a technical foundation for advanced mucosal research.

• 3D Nanotube-in-Micropillar Electrodes Enable Blood Cell Elec

  2026-07-07

  This study introduces a robust three-dimensional nanotube-in-micropillar electrode array for size-independent electroporation of blood cells, overcoming challenges of heterogeneous cell populations. The platform demonstrates high transfection efficiency and viability, supporting non-viral mRNA delivery for blood cell-based therapies.

• CKI 7 Dihydrochloride: Precision-Driven CK1 Inhibition in Tr

  2026-07-07

  Explore the mechanistic and translational significance of CKI 7 dihydrochloride as a selective Casein kinase 1 inhibitor. This article provides actionable insights for researchers targeting Wnt signaling, circadian regulation, and metastatic cancer pathways, integrating recent advances on phosphorylation-dependent metastasis suppression with practical guidance for workflow optimization.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-06

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of high-resolution separation of low molecular weight proteins and peptides (1–10 kDa), especially where conventional Tris-glycine SDS-PAGE is inadequate. It is intended for research workflows involving small protein or peptide analysis and is not appropriate for diagnostic or clinical applications.

• (-)-JQ1 in BET Bromodomain Research: Beyond the Negative Con

  2026-07-06

  Explore the nuanced role of (-)-JQ1, a JQ1 stereoisomer, in epigenetics research and advanced cancer biology studies. This article offers a deep dive into control compound design, protocol implications, and new insights from recent BET inhibition research.

16647 records 1/1110 page Next 12345 下5页 Last page